The aim of the present investigation was to develop a simple and fast method for the determination of cyclophosphamide in human plasma samples. Microextraction in packed syringe (MEPS) was used as an online rapid sample preparation method, followed by liquid chromatography with tandem mass spectrometry (LC‐MS‐MS) for the quantification of cyclophosphamide. The new method reduced the sample handling and the analysis time by several folds compared to liquid chromatography and UV detection. The limit of detection (LOD) was 0.005 µg/mL and the lower limit of quantification was 0.5 µg/mL. The accuracy of the quality control (QC) samples ranged from 95 to 106%. The inter‐day variation was within the range 5–9% while the intra day variation was between 1–5%. The calibration curve in plasma was constructed within the concentration range 0.5–150 µg/mL. The regression correlation coefficient (r) was ≥0.99 for all runs. The limit of detection improved by 100 time using MEPS‐LC‐MS/MS (0.005 µg/mL) compared to LLE‐LC‐UV (0.5 µg/mL). The present method was employed for the analysis of human plasma samples for more 170 patient samples. The concentrations obtained from LC‐MS‐MS were in good agreement with these obtained from LC‐UV with the ratio of 1.02±0.11. The present method is rapid, reliable, and robust and may be used for therapeutic drug monitoring of cyclophosphamide.
Background: Microextraction by packed sorbent (MEPS) is used as an online sample-preparation method. The determination of local anesthetics lidocaine, ropivacaine and bupivacaine directly in human blood was performed using MEPS online with LC–MS/MS. Results: The range of the calibration curves in whole blood was 10–10000 nmol/l. The lower limit of quantification was set to 10.0 nmol/l. The accuracy of the quality control samples ranged from 85 to 97%. The interday precision of the studied analytes was within the range 1–5%. The regression correlation coefficient (r2) was over 0.995 for all runs. The present method is rapid, reliable and robust and may be used for therapeutic drug monitoring of studied analytes in whole blood. Conclusion: This assay allows the analysis of drugs in human blood directly. Sample preparation is simple and automated. The assay reduced the handling time and the cost, and could handle small volumes of whole blood samples (25 µl).
Iron oxide nanozymes, which are magnetic nanoparticles with enzymatic properties, are explored, including their robust production techniques and diverse applications in the fields of biomedicine and environmental science.